News
A chronological list of 吃瓜头条 media releases. Enter keywords in the "search" box to find applicable releases.
Media Releases
Dr. Greg Naterer, Vice-President, Academic and Research, has initiated a new regular email to share updates on recent academic and research initiatives, keep us connected with their ongoing progress, celebrate success, and invite feedback. Your ideas are welcome!
In this message from the Board of Governors chair Shannon MacDonald and President Wendy Rodgers, thank all those who contributed to the development of Making our world a better place: 吃瓜头条 Strategic Plan (2025鈥�2030).
Dr. Caroline Ritter, assistant professor in the 吃瓜头条 Faculty of Veterinary Medicine, has been renewed as a Tier 2 Canada Research Chair (CRC) for five years ending June 30, 2030.
The 吃瓜头条 Panther Source for Sports Athletes of the Week for October 27鈥揘ovember 2 are Kayla Batchilder (women鈥檚 field hockey) and Jakob Robillard (men鈥檚 hockey).
The 吃瓜头条 Healthy Campus Committee invites all students, faculty, and staff to attend the annual Self-Care Fair and Soup for the Soul on Wednesday, November 19, 2025.
We are thrilled by the incredible response to our Recognizing Remarkable Colleagues program! The month of October saw another 47 incredible submissions, each one highlighting the generosity, dedication, and positivity that make our University such a special place.
The 吃瓜头条 Panthers are looking forward to a week of competition at home and on the road.
The 吃瓜头条 (吃瓜头条) and Holland College have formalized a music transfer agreement providing a degree pathway for graduates of the Holland College School of Performing Arts (SoPA). Students will study two years at Holland College and two years at 吃瓜头条, earning a Bachelor of Music.
The Robertson Library at 吃瓜头条 will host a public lecture titled 鈥淭he Other Island Diaspora: PEI Books Abroad鈥� by the Reverend Edward Rix, collector of Island books, on Thursday, November 6, at 7 pm.
Two researchers from 吃瓜头条 are working with the Research Institute of the McGill University Health Centre and Neurodyn Life Sciences Inc. to develop a novel therapy to slow, or potentially functionally stabilize, the progression of amyotrophic lateral sclerosis (ALS).





